首页> 美国卫生研究院文献>Cell Death Discovery >Systematic selection of small molecules to promote differentiation of embryonic stem cells and experimental validation for generating cardiomyocytes
【2h】

Systematic selection of small molecules to promote differentiation of embryonic stem cells and experimental validation for generating cardiomyocytes

机译:小分子的系统选择以促进胚胎干细胞的分化和用于生成心肌细胞的实验验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Small molecules are being increasingly used for inducing the targeted differentiation of stem cells to different cell types. However, until now no systematic method for selecting suitable small molecules for this purpose has been presented. In this work, we propose an integrated and general bioinformatics- and cheminformatics-based approach for selecting small molecules which direct cellular differentiation in the desired way. The approach was successfully experimentally validated for differentiating stem cells into cardiomyocytes. All predicted compounds enhanced expression of cardiac progenitor (Gata4, Nkx2-5 and Mef2c) and mature cardiac markers (Actc1, myh6) significantly during and post-cardiac progenitor formation. The best-performing compound, Famotidine, increased the percentage of Myh6-positive cells from 33 to 56%, and enhanced the expression of Nkx2.5 and Tnnt2 cardiac progenitor and cardiac markers in protein level. The approach employed in the study is applicable to all other stem cell differentiation settings where gene expression data are available.
机译:小分子正越来越多地用于诱导干细胞向不同细胞类型的定向分化。然而,到目前为止,还没有提出用于为此目的选择合适的小分子的系统方法。在这项工作中,我们提出了一种综合的,基于生物信息学和化学信息学的通用方法,用于选择以所需方式指导细胞分化的小分子。该方法已成功通过实验验证,可以将干细胞分化为心肌细胞。所有预测的化合物在心脏祖细胞形成期间和之后均显着增强了心脏祖细胞(Gata4,Nkx2-5和Mef2c)和成熟心脏标志物(Actc1,myh6)的表达。表现最佳的化合物法莫替丁可将Myh6阳性细胞的百分比从33%增加到56%,并增强Nkx2.5和Tnnt2心脏祖细胞的表达以及蛋白质水平上的心脏标志物。该研究中采用的方法适用于所有其他可获得基因表达数据的干细胞分化环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号